×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
Mutual Fund Summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Ads
Lupin may test Rs 2600-2700: Prakash Diwan
Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy
Like Sun Pharma, Strides Arcolab: Deepak Shenoy
Wait 2-3 qtrs to buy Lupin, Sun Pharma: Prabhudas Lilladher
Accumulate Sun Pharma with 18-24 months view: Devang Mehta
Prefer Glenmark Pharma: Anand Tandon
Buy Sun Pharmaceutical Industries: Mahantesh Sabarad
See downside of 5-7% in Sun Pharma: Sachin Shah
Prefer Strides Arcolab, Sun Pharma: Deepak Shenoy
Hold Reliance Industries; target Rs 980: Gaurang Shah
Hold Sun Pharma: Mayuresh Joshi
Check out: Investment ideas by market experts
Stay invested in Sun Pharma: Mayuresh Joshi
Expect upside in Sun Pharma: Abhishek Sharma
Positive on Lupin on strong pipeline for US mkt: IIFL
Invest in Sun Pharma, says Mayuresh Joshi
See 10% overall growth for Sun-Ranbaxy entity: Surajit Pal
Here are top 10 stocks to focus on March 24
Exit Biocon, says Vishal Malkan
Pharma safe space: Sandip Sabharwal
Buy Ranbaxy Labs 780 Call: VK Sharma
Here are top 10 stocks to focus on March 4
Prefer Sun Pharma, says Neeraj Deewan
Buy Lupin 1600 Call, Ranbaxy 740 Call: VK Sharma
Buy Ranbaxy, Apollo Tyres: Meghana Malkan
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio